Breaking news from “The Pink Sheet” DAILY
Executive Summary
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including FDA's "approvable" letter for Merck's COX-2 inhibitor Arcoxia, remarks by FDA's Janet Woodcock on the safety of Pfizer's COX-2 Celebrex and Bristol-Myers Squibb's third quarter earnings conference call. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...